- Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP. The genetics of inflammatory bowel disease. Aliment Pharmacol Ther 2001:15:731-48.
- Xia B, Crusius JBA, Meuwissen SGM, Peña AS. Inflammatory bowel disease: definition, epidemiology, etiology, and immunogenetic studies. World J Gastroenterol 1998;4:446-58.
- Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
- Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
- Duerr RH, Barmada MM, Zhang L, Pfützer R, Weeks DE. Highdensity genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 2000;66:1857-62.
- Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999;65:1647-55.
- Satsangi J, Parkes M, Louis E, Hashimoto L, Kalo N, Welsh K, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3,7 and 12. Nat Genet 1996;14:199-202.
- Rioux JD, DaIy MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001;29:223-8.
- Harper K, Balzano C, Rouvier E, Mattel MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991;147:1037-44.
- Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001;19:225-52.
- Waterhous e P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, et al. Lymphoproliferativ e disorders with early lethality in mice deficient in CTLA-4. Science 1995;270:985-8.
- Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993;261:609-12.
- Liu Z, Geboes K, Hellings P, Maerten P, Heremans H, Vandenberghe P, et al. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. J Immunol 2001;167:1830-8.
- Buonavista N, Balzano C, Pontarotti P, Le Paslier D, Golstein P. Molecular linkage of the human CTLA4 and CD28 Ig-superfamily genes in yeast artificial chromosomes. Genomics 1992; 13:856-61.
- Deichmann K, Heinzmann A, Bruggenolte E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA4 promoter. Biochem Biophys Res Commun 1996;225:817-8.
- Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum MoI Genet 1996;5:1075-80.
- Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Dinucleotide repeat polymorphism at the human CTLA4 gene. Nucleic Acids Res 1991:19:4018.
- Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesi s of Graves' disease. J Immunol 2000;165:660611.
- Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001:2:145-52.
- Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997:82:143-6.
- Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MTM, et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum MoI Genet 1997:6:1275-82.
- Lee YJ, Huang FY, Lo FS, Wang WC, Hsu CH, Kao HA, et al. Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children. Clin Endocrinol (Oxf) 2000; 52:153-7.
- Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 1997:82:4130-2.
- Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, et al. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997;7:843-6.
- Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995;80:41 -5.
- Farmer MA, Sundberg JP, Bristol LT, Churchill GA, Li R, Elson CO, et al. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sei USA 2001:13:13820-5.
- Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6.
- Gasche C, Schölmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
- Agarwal K, Jones DEEJ, Aithal G, DaIy A, Bassendine MF, Hudson M. CTLA-4 gene polymorphism and susceptibility to inflammatory bowel disease (IBD). Gut 1999;44 Suppl 1:A42.
- Holopainen PM, Partanen JA. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol 2001:167:2457-8.
- Huang D, Giscombe R, Zhou Y, Pirskanen R, Lefvert AK. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in my asthenia gravis. J Neuroimmunol 2000:105:69-77.
- Hizawa N, Yamaguchi E, Jinushi E, Konno S, Kawakami Y, Nishimura M. Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCERlB. J Allergy Clin Immunol 2001:108:74-9.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 11